» Articles » PMID: 28239271

Why Do We Still Have Helicobacter Pylori in Our Stomachs

Overview
Specialty General Medicine
Date 2017 Feb 28
PMID 28239271
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The existence of any infectious agent in a highly acidic human stomach is contentious, but the chance finding of is by no means an accident. Once colonises the gastric mucosa, it can persist for a lifetime, and it is intriguing why our immune system is able to tolerate its existence. Some conditions favour the persistence of in the stomach, but other conditions oppose the colonisation of this bacterium. Populations with high and extremely low prevalence of provide useful insights on the clinical outcomes that are associated with this type of infection. Adverse clinical outcomes including peptic ulcer disease and gastric cancer depend on a delicate balance between a harmless inflammation and a more severe kind of inflammation. Is the only good really a dead ? The jury is still out.

Citing Articles

Global trends of cancer: The role of diet, lifestyle, and environmental factors.

Bahrami H, Tafrihi M Cancer Innov. 2023; 2(4):290-301.

PMID: 38089751 PMC: 10686168. DOI: 10.1002/cai2.76.


Frequency and risk factors of H. pylori infection among dental students: an observational cross-sectional study.

Mikhail C, Abd El Maksoud Mohamed A, Shaker O, Desouky E, Shalaby R Sci Rep. 2023; 13(1):14264.

PMID: 37653065 PMC: 10471685. DOI: 10.1038/s41598-023-41246-7.


Prevalence of Helicobacter pylori genotypes: cagA, vacA (m1), vacA (s1), babA2, dupA, iceA1, oipA and their association with gastrointestinal diseases. A cross-sectional study in Quito-Ecuador.

Bustos-Fraga S, Salinas-Pinta M, Vicuna-Almeida Y, de Oliveira R, Baldeon-Rojas L BMC Gastroenterol. 2023; 23(1):197.

PMID: 37280541 PMC: 10246408. DOI: 10.1186/s12876-023-02838-9.


Potential contribution of Helicobacter pylori proteins in the pathogenesis of type 1 gastric neuroendocrine tumor and urticaria. In silico approach.

Sanchez Caraballo A, Guzman Y, Sanchez J, Munera M, Garcia E, Gonzalez-Devia D PLoS One. 2023; 18(4):e0281485.

PMID: 37098080 PMC: 10128923. DOI: 10.1371/journal.pone.0281485.


Cancer-associated fibroblast related gene signature in Helicobacter pylori-based subtypes of gastric carcinoma for prognosis and tumor microenvironment estimation analysis.

Xu R, Yang L, Zhang Z, Liao Y, Yu Y, Zhou D Front Med (Lausanne). 2023; 10:1079470.

PMID: 36744128 PMC: 9889637. DOI: 10.3389/fmed.2023.1079470.


References
1.
Troost E, Hold G, Smith M, Chow W, Rabkin C, McColl K . The role of interleukin-1beta and other potential genetic markers as indicators of gastric cancer risk. Can J Gastroenterol. 2003; 17 Suppl B:8B-12B. DOI: 10.1155/2003/397060. View

2.
Talebi Bezmin Abadi A, Taghvaei T, Wolfram L, Kusters J . Infection with Helicobacter pylori strains lacking dupA is associated with an increased risk of gastric ulcer and gastric cancer development. J Med Microbiol. 2011; 61(Pt 1):23-30. DOI: 10.1099/jmm.0.027052-0. View

3.
Abadi A, Taghvaei T, Ghasemzadeh A, Mobarez A . High frequency of A2143G mutation in clarithromycin-resistant Helicobacter pylori isolates recovered from dyspeptic patients in Iran. Saudi J Gastroenterol. 2011; 17(6):396-9. PMC: 3221114. DOI: 10.4103/1319-3767.87181. View

4.
Talebi Bezmin Abadi A . Therapy of Helicobacter pylori: present medley and future prospective. Biomed Res Int. 2014; 2014:124607. PMC: 3988734. DOI: 10.1155/2014/124607. View

5.
Lee Y, Noridah N, Syed Hassan S, Menon J . Absence of Helicobacter pylori is not protective against peptic ulcer bleeding in elderly on offending agents: lessons from an exceptionally low prevalence population. PeerJ. 2014; 2:e257. PMC: 3932736. DOI: 10.7717/peerj.257. View